<DOC>
	<DOC>NCT02647853</DOC>
	<brief_summary>This Phase 1, randomized, placebo-controlled, double-blind, healthy volunteer study tested the safety, tolerability, and plasma pharmacokinetics of two different concentrations of TAT4 Gel administered once daily to 50 cm2 of skin for 14 days.</brief_summary>
	<brief_title>Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Lipodystrophy</mesh_term>
	<criteria>Men and women 4070 years old Healthy volunteers Provision of informed consent History of skin hypersensitivity Abnormality on screening assessments</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>